fda compounding semaglutide news today 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non- FDA-approved compounded "semaglutide" New Study Finds Compounded GLP-1s

It may require an adjustment of your dosage, or your doctor may decide to take you off the medication entirely

Viral gastroenteritis Only one trial was evaluated regarding the risk of viral gastroenteritis in patients receiving GLP-1 RAs

Contact Yvonne Rhodes, Director of Strategic Communications and Operations, [email protected] About ECRI ECRI is an independent, nonprofit organization improving the safety and quality of healthcare

Chemical peeling helps exfoliate the skin, while microcurrent encourages greater blood flow

1840(1): p

Food and Drug Administration approved a once-daily oral version of Wegovy (semaglutide) in December 2025 for chronic weight management in adults meeting specific clinical criteria